SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001787306-23-000068
Filing Date
2023-06-05
Accepted
2023-06-02 21:36:15
Documents
12
Period of Report
2023-06-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20230602.htm   iXBRL 8-K 44183
  Complete submission text file 0001787306-23-000068.txt   184401

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20230602.xsd EX-101.SCH 1887
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20230602_lab.xml EX-101.LAB 25154
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20230602_pre.xml EX-101.PRE 13036
6 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20230602_htm.xml XML 11302
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 23991075
SIC: 2834 Pharmaceutical Preparations